328 related articles for article (PubMed ID: 30948018)
21. Nanobodies as Probes for Protein Dynamics in Vitro and in Cells.
Dmitriev OY; Lutsenko S; Muyldermans S
J Biol Chem; 2016 Feb; 291(8):3767-75. PubMed ID: 26677230
[TBL] [Abstract][Full Text] [Related]
22. Development, Screening, and Validation of Camelid-Derived Nanobodies for Neuroscience Research.
Gavira-O'Neill CE; Dong JX; Trimmer JS
Curr Protoc Neurosci; 2020 Dec; 94(1):e107. PubMed ID: 33185319
[TBL] [Abstract][Full Text] [Related]
23. The development of nanobodies for therapeutic applications.
Van Bockstaele F; Holz JB; Revets H
Curr Opin Investig Drugs; 2009 Nov; 10(11):1212-24. PubMed ID: 19876789
[TBL] [Abstract][Full Text] [Related]
24. Camelid single-domain antibody fragments: Uses and prospects to investigate protein misfolding and aggregation, and to treat diseases associated with these phenomena.
Pain C; Dumont J; Dumoulin M
Biochimie; 2015 Apr; 111():82-106. PubMed ID: 25656912
[TBL] [Abstract][Full Text] [Related]
25. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
Bannas P; Hambach J; Koch-Nolte F
Front Immunol; 2017; 8():1603. PubMed ID: 29213270
[TBL] [Abstract][Full Text] [Related]
26. Joining the in vitro immunization of alpaca lymphocytes and phage display: rapid and cost effective pipeline for sdAb synthesis.
Comor L; Dolinska S; Bhide K; Pulzova L; Jiménez-Munguía I; Bencurova E; Flachbartova Z; Potocnakova L; Kanova E; Bhide M
Microb Cell Fact; 2017 Jan; 16(1):13. PubMed ID: 28114943
[TBL] [Abstract][Full Text] [Related]
27. Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.
Wesolowski J; Alzogaray V; Reyelt J; Unger M; Juarez K; Urrutia M; Cauerhff A; Danquah W; Rissiek B; Scheuplein F; Schwarz N; Adriouch S; Boyer O; Seman M; Licea A; Serreze DV; Goldbaum FA; Haag F; Koch-Nolte F
Med Microbiol Immunol; 2009 Aug; 198(3):157-74. PubMed ID: 19529959
[TBL] [Abstract][Full Text] [Related]
28. Single domain camel antibodies: current status.
Muyldermans S
J Biotechnol; 2001 Jun; 74(4):277-302. PubMed ID: 11526908
[TBL] [Abstract][Full Text] [Related]
29. Antibody repertoire development in camelids.
De Genst E; Saerens D; Muyldermans S; Conrath K
Dev Comp Immunol; 2006; 30(1-2):187-98. PubMed ID: 16051357
[TBL] [Abstract][Full Text] [Related]
30. Nanobodies as efficient drug-carriers: Progress and trends in chemotherapy.
Panikar SS; Banu N; Haramati J; Del Toro-Arreola S; Riera Leal A; Salas P
J Control Release; 2021 Jun; 334():389-412. PubMed ID: 33964364
[TBL] [Abstract][Full Text] [Related]
31. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
[TBL] [Abstract][Full Text] [Related]
32. Generation of nanobodies from transgenic 'LamaMice' lacking an endogenous immunoglobulin repertoire.
Eden T; Schaffrath AZ; Wesolowski J; Stähler T; Tode N; Richter N; Schäfer W; Hambach J; Hermans-Borgmeyer I; Woens J; Le Gall CM; Wendler S; Linke-Winnebeck C; Stobbe M; Budnicki I; Wanney A; Heitz Y; Schimmelpfennig L; Schweitzer L; Zimmer D; Stahl E; Seyfried F; Gebhardt AJ; Dieckow L; Riecken K; Fehse B; Bannas P; Magnus T; Verdoes M; Figdor CG; Hartlepp KF; Schleer H; Füner J; Tomas NM; Haag F; Rissiek B; Mann AM; Menzel S; Koch-Nolte F
Nat Commun; 2024 Jun; 15(1):4728. PubMed ID: 38830864
[TBL] [Abstract][Full Text] [Related]
33. Structural Basis of Epitope Recognition by Heavy-Chain Camelid Antibodies.
Zavrtanik U; Lukan J; Loris R; Lah J; Hadži S
J Mol Biol; 2018 Oct; 430(21):4369-4386. PubMed ID: 30205092
[TBL] [Abstract][Full Text] [Related]
34. High-expression of monoclonal nanobodies used in the preparation of HRP-conjugated second antibody.
Ahmadvand D; Rahbarizadeh F; Vishteh VK
Hybridoma (Larchmt); 2008 Aug; 27(4):269-76. PubMed ID: 18707545
[TBL] [Abstract][Full Text] [Related]
35. Generation and characterization of nanobodies against rhGH expressed as sfGFP fusion protein.
Abbady AQ; Al-Shemali R; Mir Assaad J; Murad H
Gen Comp Endocrinol; 2014 Aug; 204():33-42. PubMed ID: 24859761
[TBL] [Abstract][Full Text] [Related]
36. Expression cloning of camelid nanobodies specific for Xenopus embryonic antigens.
Itoh K; Sokol SY
PLoS One; 2014; 9(10):e107521. PubMed ID: 25285446
[TBL] [Abstract][Full Text] [Related]
37. Streamlined method for parallel identification of single domain antibodies to membrane receptors on whole cells.
Rossotti M; Tabares S; Alfaya L; Leizagoyen C; Moron G; González-Sapienza G
Biochim Biophys Acta; 2015 Jul; 1850(7):1397-404. PubMed ID: 25819371
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the binding loops configuration and surface adaptation of different crystallized single-domain antibodies in response to various antigens.
Al Qaraghuli MM; Ferro VA
J Mol Recognit; 2017 Apr; 30(4):. PubMed ID: 27862476
[TBL] [Abstract][Full Text] [Related]
39. [Preparation and identification of anti-follicle-stimulating hormone receptor nanobodies].
Xia X; M M; Zhai T; Li J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):829-33. PubMed ID: 23948408
[TBL] [Abstract][Full Text] [Related]
40. Preparation of a naïve library of camelid single domain antibodies.
Olichon A; de Marco A
Methods Mol Biol; 2012; 911():65-78. PubMed ID: 22886246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
